Y10S 530/827
Proteins from mammals or birds
Y10S530/827 (Proteins from mammals or birds) appears on 2,167 US grants and 809 published applications in this corpus.
Search patents in Y10S- Granted patents
- 2,167
- Published applications
- 809
- Assignees
- 848
- Inventors
- 3,003
- Latest grant
- 14 May 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 28 | 0 |
| 1977 | 36 | 0 |
| 1978 | 53 | 0 |
| 1979 | 40 | 0 |
| 1980 | 48 | 0 |
| 1981 | 50 | 0 |
| 1982 | 55 | 0 |
| 1983 | 65 | 0 |
| 1984 | 66 | 0 |
| 1985 | 63 | 0 |
| 1986 | 21 | 0 |
| 1987 | 35 | 0 |
| 1988 | 38 | 0 |
| 1989 | 72 | 0 |
| 1990 | 62 | 0 |
| 1991 | 77 | 0 |
| 1992 | 68 | 0 |
| 1993 | 63 | 0 |
| 1994 | 70 | 0 |
| 1995 | 61 | 0 |
| 1996 | 84 | 0 |
| 1997 | 109 | 0 |
| 1998 | 120 | 0 |
| 1999 | 126 | 0 |
| 2000 | 103 | 0 |
| 2001 | 68 | 12 |
| 2002 | 57 | 55 |
| 2003 | 57 | 474 |
| 2004 | 29 | 64 |
| 2005 | 24 | 50 |
| 2006 | 38 | 30 |
| 2007 | 91 | 21 |
| 2008 | 78 | 20 |
| 2009 | 27 | 18 |
| 2010 | 21 | 17 |
| 2011 | 24 | 10 |
| 2012 | 14 | 3 |
| 2013 | 5 | 6 |
| 2014 | 7 | 9 |
| 2015 | 6 | 4 |
| 2016 | 3 | 5 |
| 2017 | 4 | 4 |
| 2018 | 0 | 0 |
| 2019 | 1 | 3 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Mitochondrial proteins constructs and uses thereof14 May 2019US 10,287,331 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Immunoglobulin reduced in thrombogenic agents and preparation thereof24 Oct 2017US 9,796,770 B2Omrix Biopharmaceuticals Ltd.
- Albumin-free factor VIII formulations6 Jun 2017US 9,669,076 B2Baxalta Incorporated
- Sperm-specific cation channel, Catsper2, and uses therefor11 Apr 2017US 9,618,521 B2Board of Regents, The University of Texas System
- NPP1 fusion proteins10 Jan 2017US 9,540,621 B2Alexion Pharmaceuticals, Inc.
- NPP1 Fusion Proteins22 Jan 2026US 2026/0022356 A1Inozyme Pharma, Inc.
- Npp1 fusion proteins27 Apr 2023US 2023/0129977 A1Inozyme Pharma, Inc.
- Npp1 fusion proteins30 Sep 2021US 2021/0301268 A1Inozyme Pharma, Inc.
- Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders9 Jul 2020US 2020/0215209 A1BioArctic AB
- Sustained release composition14 Nov 2019US 2019/0343111 A1Spermvital AS
Most cited
By later US patents
- Adhesive sealant composition1,238US 5,583,114 AMinnesota Mining and Manufacturing Company · 1996
- Controlled release formulations of trophic factors in ganglioside-lipsome vehicle653US 5,073,543 AG. D. Searle & Co. · 1991
- Method for treating connective tissue disorders633US 5,226,914 A1993
- Antibody conjugates for the delivery of compounds to target sites546US 4,671,958 ACytogen Corporation · 1987
- Isolation of exogenous recombinant proteins from the milk of transgenic mammals500US 4,873,316 ABiogen, Inc. · 1989